19 results
A1C and eAG
~
*For Educational Purposes Only*

#Diabetes #T2D #DM2 #Table #PrimaryCare #Endocrinology #BloodGlucose #A1C
A1C and eAG ~ ... Purposes Only* #Diabetes ... #T2D #DM2 #Table ... #PrimaryCare #Endocrinology
Diabetes Insipidus vs Syndrome of Inappropriate ADH (SIADH) - Comparison Table

Diabetes Insipidus - Inadequate ADH
SIADH -
Diabetes Insipidus ... ) - Comparison Table ... SIADH #Comparison #Table ... #Pathophysiology ... Symptoms #Diagnosis #Endocrinology
Ketosis Disorders - Comparison Table
 • Starvation Ketosis
 • Alcoholic Ketoacidosis (AKA)
 • Diabetic Ketoacidosis (DKA)
Disorders - Comparison Table ... Ketoacidosis (AKA) • Diabetic ... Disorders #ketones #differential ... #diagnosis #management ... #endocrinology
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... manage Type 2 diabetes ... pharmacotherapy #table ... #comparison #management ... #endocrinology
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
#SideEffects #Table ... DecisionAid #Orals #DM2 #Diabetes ... #Endocrinology ... #Pharmacology #Management
Diabetic Ketoacidosis (DKA) - Diagnosis and Management Summary

Symptoms:
• Abdominal pain
• Nausea
• Polyuria
• Polydipsia
• Vomiting
• Weight loss
•
Diabetic Ketoacidosis ... Diagnosis and Management ... ) pH > 7.3 3) AG ... mg/dL #DKA #Diabetic ... #Endocrinology
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... #medications #table ... #comparison #management ... #endocrinology
Diabetic Ketoacidosis (DKA) - Diagnosis and Management Summary

Symptoms:
• Abdominal pain
• Nausea
• Polyuria
• Polydipsia
• Vomiting
• Weight loss
•
Diabetic Ketoacidosis ... Diagnosis and Management ... ) pH > 7.3 3) AG ... mg/dL #DKA #Diabetic ... #Endocrinology
Euglycemic Diabetic Ketoacidosis (EuDKA)
SGLT2 Inhibitors
Increasing Indications
Significant Adverse Drug Effects
Definition of EuDKA
 • Metabolic acidosis with pH
Euglycemic Diabetic ... level < 200 mg/dL Pathophysiology ... #Euglycemic #Diabetic ... EuDKA #diagnosis #management ... #endocrinology
Ascites - Diagnosis and Management Summary
Paracentesis studies: cell count + differential, albumin, protein, culture
 • Serum-ascites-albumin-gradient
Diagnosis and Management ... : cell count + differential ... Serum-ascites-albumin-gradient (SAAG ... Ascites #Diagnosis #Management ... Summary #Hepatology #SAAG